Detalhe da pesquisa
1.
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
Clin Infect Dis
; 73(10): 1831-1839, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639620
2.
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.
Clin Infect Dis
; 73(9): e3120-e3123, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300579
3.
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020.
Clin Infect Dis
; 72(12): e1004-e1009, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252659
4.
Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.
Biologicals
; 57: 9-20, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458978
5.
Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel.
Access Microbiol
; 6(2)2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482357
6.
Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
J Immunol Methods
; 333(1-2): 89-106, 2008 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18304568